FDA approved medicines may cause safety risks
Contemporary Long-Term Care Weekly, April 3, 2008
Medications approved by the Food and Drug Administration (FDA) on deadline, rather than ahead of deadline, are more likely to cause safety problems, the Washington Post reports.
A Harvard report published in the New England Journal of Medicine looked at decades of drug approvals and found that medications approved just prior to deadline had a four- to five-fold greater rate of having approval withdrawn or additional safety warnings issued when compared with those that are approved quickly or miss the appointed deadline.
Comments
0 comments on “FDA approved medicines may cause safety risks ”
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched
